Raymond James Trust’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,298
Closed -$60K 980
2019
Q3
$60K Hold
10,298
﹤0.01% 928
2019
Q2
$33K Hold
10,298
﹤0.01% 907
2019
Q1
$42K Hold
10,298
﹤0.01% 874
2018
Q4
$65K Hold
10,298
﹤0.01% 808
2018
Q3
$170K Hold
10,298
0.01% 832
2018
Q2
$172K Hold
10,298
0.01% 798
2018
Q1
$160K Hold
10,298
0.01% 682
2017
Q4
$194K Sell
10,298
-9,644
-48% -$214K 0.01% 691
2017
Q3
$582K Sell
19,942
-1,805
-8% -$53.3K 0.04% 336
2017
Q2
$700K Sell
21,747
-260
-1% -$8.53K 0.05% 299
2017
Q1
$762K Buy
22,007
+10
+0% +$357 0.06% 284
2016
Q4
$776K Buy
21,997
+1,666
+8% +$56.3K 0.06% 268
2016
Q3
$706K Buy
20,331
+3,101
+18% +$109K 0.06% 281
2016
Q2
$644K Buy
17,230
+118
+0.7% +$4.43K 0.06% 286
2016
Q1
$692K Sell
17,112
-310
-2% -$11.5K 0.06% 265
2015
Q4
$627K Sell
17,422
-259
-1% -$9.37K 0.06% 294
2015
Q3
$565K Buy
17,681
+328
+2% +$11.2K 0.06% 277
2015
Q2
$590K Buy
17,353
+226
+1% +$7.61K 0.06% 279
2015
Q1
$579K Sell
17,127
-4,777
-22% -$166K 0.06% 287
2014
Q4
$769K Buy
21,904
+3,154
+17% +$106K 0.08% 238
2014
Q3
$614K Buy
18,750
+12,513
+201% +$426K 0.07% 263
2014
Q2
$212K Buy
+6,237
New +$214K 0.02% 538

Other funds holding ACH

Raymond James Trust's ACH Position: Q4 2019 in Review

Raymond James Trust sold out of Accendra Health (ACH) in Q4 2019, closing a stake of 10,298 shares — an estimated $60K sold.

Raymond James Trust first reported a position in ACH in Q2 2014 and held it in 22 quarters. The position peaked at $776K in Q4 2016. 180 funds tracked by Wall St. Rank hold ACH as of Q4 2019.

  • Raymond James Trust reported no remaining Accendra Health position as of Q4 2019 after selling out during the quarter.
  • Raymond James Trust sold 10,298 Accendra Health shares in Q4 2019, an estimated $60K.
  • Raymond James Trust first reported a position in Accendra Health in Q2 2014 and held it in 22 quarters.
  • Raymond James Trust's Accendra Health position peaked at $776K in Q4 2016.
  • 180 funds tracked by Wall St. Rank held Accendra Health as of Q4 2019.

Based on Raymond James Trust's 13F filing for Q4 2019, filed 14 Jan 2020.